BP180 AntibodiesLab InterpretationDermatology A positive BP180 result supports an autoimmune skin disorder, but the number ...
KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...
Eli Lilly and Company ha anunciado los resultados a 52 semanas de dos innovadores ensayos clínicos fase 3b, abiertos, que ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results